" /> B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 - CISMeF





Preferred Label : B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1;

NCIt synonyms : B-Cell Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1; Philadelphia Positive Precursor Lymphoblastic Leukemia; Philadelphia Positive Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1; Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive; B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1; B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1; B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1; B-Acute Lymphoblastic Leukemia with BCR::ABL1 Fusion; B Acute Lymphoblastic Leukemia with BCR::ABL1 Fusion; B-Acute Lymphoblastic Leukemia with BCR-ABL1 Fusion; B Acute Lymphoblastic Leukemia with BCR-ABL1 Fusion;

NCIt definition : A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.;

Neoplastic status : Malignant;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
08/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.